AIDS patients have increased surfactant protein D but normal mannose binding lectin levels in lung fluid

被引:20
作者
Jambo, Kondwani C.
French, Neil
Zijlstra, Ed
Gordon, Stephen B. [1 ]
机构
[1] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England
[2] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi
[3] London Sch Hyg & Trop Med, LEPRA Karonga Prevent Study, Wellcome Trust, Chiluma, Malawi
[4] Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi
基金
英国惠康基金;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; PULMONARY SURFACTANT; HOST-DEFENSE; INFECTION; PNEUMONIA; DISEASE; PHAGOCYTOSIS; MACROPHAGES; PROGRESSION;
D O I
10.1186/1465-9921-8-42
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Surfactant protein D (SP-D) and Mannose Binding Lectin (MBL) are collectins that have opsonic and immunoregulatory functions, are found in lung fluid and interact with the human immunodeficiency virus (HIV). We compared collectin levels in lung fluid and serum from HIV infected and normal subjects to determine if alterations in lung collectin levels were associated with HIV infection and might result in increased susceptibility to other pulmonary infections. Methods: Blood and bronchoalveolar lavage samples were collected from 19 HIV-infected individuals and 17 HIV-uninfected individuals, all with normal chest X ray at time of study. HIV viral loads and peripheral blood CD4+ T cell counts were measured in all subjects. SP-D was measured in lung fluid, and MBL in both lung fluid and serum. Results: SP-D levels were not significantly different in lung fluid from HIV-uninfected (median 406.72 ng/ml) and HIV-infected individuals with high CD4 count (CD4 > 200) (median 382.60 ng/ml) but were elevated in HIV-infected individuals with low CD4 count (median 577.79 ng/ml; Kruskall Wallis p < 0.05). MBL levels in serum were not significantly different between HIV-uninfected and HIV-infected individuals (median 1782.70 ng/ml vs 2639.73 ng/ml) and were not detectable in lung fluid. Conclusion: SP-D levels are increased in lung fluid from AIDS patients but not in patients with early HIV infection. MBL levels are not altered by HIV infection or AIDS. There is no evidence that altered pulmonary collectin levels result in susceptibility to infection in these patients.
引用
收藏
页数:6
相关论文
共 26 条
[1]   Pulmonary surfactant proteins a and D directly suppress CD3+/CD4+ cell function:: Evidence for two shared mechanisms1 [J].
Borron, PJ ;
Mostaghel, EA ;
Doyle, C ;
Walsh, ES ;
McHeyzer-Williams, MG ;
Wright, JR .
JOURNAL OF IMMUNOLOGY, 2002, 169 (10) :5844-5850
[2]   Collectins and pulmonary host defense [J].
Crouch, EC .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1998, 19 (02) :177-201
[3]  
Davies J, 2001, Paediatr Respir Rev, V2, P70, DOI 10.1053/prrv.2000.0104
[4]   A HUMAN-SERUM MANNOSE-BINDING PROTEIN INHIBITS INVITRO INFECTION BY THE HUMAN IMMUNODEFICIENCY VIRUS [J].
EZEKOWITZ, RAB ;
KUHLMAN, M ;
GROOPMAN, JE ;
BYRN, RA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (01) :185-196
[5]   Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin [J].
Garred, P ;
Madsen, HO ;
Balslev, U ;
Hofmann, B ;
Pedersen, C ;
Gerstoft, J ;
Svejgaard, A .
LANCET, 1997, 349 (9047) :236-240
[6]  
Garred P, 1999, LANCET, V354, P336, DOI 10.1016/S0140-6736(05)75241-7
[7]   Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections [J].
Gomi, K ;
Tokue, Y ;
Kobayashi, T ;
Takahashi, H ;
Watanabe, A ;
Fujita, T ;
Nukiwa, T .
CHEST, 2004, 126 (01) :95-99
[8]   Opsonic phagocytosis of Streptococcus pneumoniae by alveolar macrophages is not impaired in human immunodeficiency virus infected Malawian adults [J].
Gordon, SB ;
Molyneux, ME ;
Boeree, MJ ;
Kanyanda, S ;
Chaponda, M ;
Squire, SB ;
Read, RC .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (10) :1345-1349
[9]   BACTERIAL PNEUMONIA IN PERSONS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS [J].
HIRSCHTICK, RE ;
GLASSROTH, J ;
JORDAN, MC ;
WILCOSKY, TC ;
WALLACE, JM ;
KVALE, PA ;
MARKOWITZ, N ;
ROSEN, MJ ;
MANGURA, BT ;
HOPEWELL, PC ;
STANSELL, J ;
TURNER, J ;
OSMOND, D ;
MERRIFIELD, C ;
MOSSAR, M ;
HIRSCHTICK, R ;
MEISELMAN, L ;
MANGHISI, KJ ;
SCHNEIDER, RF ;
REICHMAN, LB ;
MANGURA, B ;
BARNES, S ;
RICHER, B ;
AU, J ;
COULSON, A ;
CLEMENTE, V ;
SARAVOLATZ, LD ;
JOHNSON, C ;
HUITSING, J ;
KRYSTOFORSKI, A ;
POOLE, WK ;
RAO, AV ;
CLAYTON, K ;
HANSON, N ;
JORDAN, M ;
THOMPSON, J ;
MYERS, D ;
LAVANGE, L ;
KATZIN, J ;
FULKERSON, W ;
WILCOSKY, T ;
LOU, Y ;
KALICA, AR ;
WITTES, J ;
FOLLMANN, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (13) :845-851
[10]  
HOLMSKOV U, 1998, ANNU REV IMMUNOL, V9, P683